$PVLA

$146.33▲ -0.2% YTD

12 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History

News

PVLA ▼ -0.2% - Palvella Therapeutics, Inc.

CP $146.33▲ -0.2%Nov 3, 2026 · ThinkSabio Blog

$PVLA - Palvella Therapeutics to Participate in the Stifel 2026 Healthcare Conference…

News

PVLA ▼ -2.9% - Palvella Therapeutics, Inc.

CP $143.30▲ -2.9%Oct 29, 2026 · ThinkSabio Blog

$PVLA - Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026…

SEC 13D/G

PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (28-OCT-2026) | ThinkSabio - Stocks Simplified

$146.02▲ 45.24%Oct 28, 2026 · ThinkSabio Blog

$PVLA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PVLA Palvella Therapeutics, Inc. : $146.02 Sector: Healthcare |…

News

PVLA ▲ +2.1% - Palvella Therapeutics, Inc.

CP $136.00▲ +2.1%Oct 28, 2026 · ThinkSabio Blog

$PVLA - Palvella Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set…

News

PVLA ▲ +0.0% - Palvella Therapeutics, Inc.

CP $134.00▲ +0.0%Oct 13, 2026 · ThinkSabio Blog

$PVLA - Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference…

News

PVLA ▼ -0.1% - Palvella Therapeutics, Inc.

CP $138.77▲ -0.1%Oct 12, 2026 · ThinkSabio Blog

$PVLA - Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clini…

News

PVLA ▲ +0.5% - Palvella Therapeutics, Inc.

CP $153.05▲ +0.5%Sep 9, 2026 · ThinkSabio Blog

$PVLA - Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer…

SEC 13D/G

PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$156.13▲ 55.29%Aug 14, 2026 · ThinkSabio Blog

$PVLA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PVLA Palvella Therapeutics, Inc. : $156.13 Sector: Healthcare |…

SEC 13D/G

PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$156.13▲ 55.29%Aug 14, 2026 · ThinkSabio Blog

$PVLA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PVLA Palvella Therapeutics, Inc. : $156.13 Sector: Healthcare |…

SEC 13D/G

PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks Simplified

$154.62▲ 53.79%Aug 10, 2026 · ThinkSabio Blog

$PVLA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PVLA Palvella Therapeutics, Inc. : $154.62 Sector: Healthcare |…

SEC 13D/G

$PVLA SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks Simplified

$141.38▲ 40.62%Aug 3, 2026 · ThinkSabio Blog

$PVLA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PVLA : $141.38 Sector: Healthcare | YTD: 🔼+ 40.62% The SEC disc…

SEC 13D/G

$PVLA SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks Simplified

$143.84▲ 43.07%Jul 29, 2026 · ThinkSabio Blog

$PVLA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PVLA : $143.84 Sector: Healthcare | YTD: 🔼+ 43.07% The SEC disc…